<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4108437</article-id><article-id pub-id-type="publisher-id">PONE-D-14-30766</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0103925</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>The <italic>PLOS ONE</italic> Staff</collab></contrib></contrib-group><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>23</day><month>7</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>7</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>9</volume><issue>7</issue><elocation-id>e103925</elocation-id><permissions><copyright-statement>&#x000a9; 2014 The PLOS ONE Staff</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>The PLOS ONE Staff</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><related-article id="d35e64" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1371/journal.pone.0096187" page="e96187">
<article-title>Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial</article-title>
</related-article><counts><page-count count="1"/></counts></article-meta></front><body><p>There is an error in the Materials and Methods section. In the first sentence of the subheading &#x0201c;Design and Intervention&#x0201d;, the ATV dosage is incorrect. The correct ATV dosage is 400 mg. Please note that the dosage is correct in the Supporting Information protocol.</p></body><back><ref-list><title>Reference</title><ref id="pone.0103925-Wohl1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Wohl</surname><given-names>DA</given-names></name>, <name><surname>Bhatti</surname><given-names>L</given-names></name>, <name><surname>Small</surname><given-names>CB</given-names></name>, <name><surname>Edelstein</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>HH</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial</article-title>. <source>PLoS ONE</source>
<volume>9(5)</volume>: <fpage>e96187</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0096187">10.1371/journal.pone.0096187</ext-link></comment>
<pub-id pub-id-type="pmid">24825167</pub-id></mixed-citation></ref></ref-list></back></article>